Community Advisory Board of Keiro Pacifica Senior Care Facilities Raises Concerns About Protecting Residents from COVID-19

LOS ANGELES–(BUSINESS WIRE)–The Community Advisory Board of the Keiro Pacifica properties, which was formed by order of the California Attorney General five years ago as a condition of the sale of the facilities, today raises concerns about the potential transfer of patients and closure of a facility that has so far not had a single … [Read more…]

Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021

HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the fourth quarter and full year 2020 on Thursday, February 11, 2021, following the close of the market. The company will discuss these results in a conference call scheduled for … [Read more…]

Cross Country Healthcare Announces New Executive Leadership

BOCA RATON, Fla.–(BUSINESS WIRE)–Cross Country Healthcare, Inc. (Nasdaq: CCRN), a leading provider of total talent management, including workforce solutions, contingent staffing, permanent placement and other consultative services for healthcare clients, announced that John A. Martins, 52, has joined the Company as Group President, Nurse and Allied, effective today. Mr. Martins has over 15 years of … [Read more…]

Alexion to Report Fourth Quarter and Full Year 2020 Results on Thursday, February 4, 2021

BOSTON–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2020 before the US financial markets open on February 4, 2021. Given the recently announced agreement to be acquired by AstraZeneca, Alexion will not be hosting a conference call. … [Read more…]

Axonics® Reports Preliminary Fourth Quarter and Fiscal Year 2020 Revenue

IRVINE, Calif.–(BUSINESS WIRE)–Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, today reported preliminary unaudited net revenue for the three months and fiscal year ended December 31, 2020. Preliminary unaudited net revenue is expected … [Read more…]

KORU Medical Systems Reports Preliminary Full Year 2020 Results; Announces CEO Transition

CHESTER, N.Y.–(BUSINESS WIRE)–Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported preliminary financial results for the full year ended December 31, … [Read more…]

Nanobiotix Subsidiary Curadigm Secures New Collaboration Agreement With Sanofi Focused on Gene Therapy Pipeline

Nanobiotix subsidiary, Curadigm, submitted a research project involving its Nanoprimer technology which was selected for the Sanofi iTech Awards Program, as a highly promising option to significantly improve gene therapy development Following this selection, Curadigm will enter into a one-year agreement with the pharmaceutical company including direct funding and scientific exchanges This selection provides an … [Read more…]

Nanobiotix Subsidiary Curadigm Secures New Collaboration Agreement With Sanofi Focused on Gene Therapy Pipeline

Nanobiotix subsidiary, Curadigm, submitted a research project involving its Nanoprimer technology which was selected for the Sanofi iTech Awards Program, as a highly promising option to significantly improve gene therapy development Following this selection, Curadigm will enter into a one-year agreement with the pharmaceutical company including direct funding and scientific exchanges This selection provides an … [Read more…]

Curadigm Announces Collaboration With Sanofi as Part of the Sanofi iTech Awards Program

– Curadigm’s project involving its proprietary Nanoprimer technology has been selected as part of the Sanofi iTech Awards Program as a highly promising option to significantly improve gene therapy development – This selection is formalized through a one-year agreement with Sanofi, coming with 100k€ in funding and scientific exchanges – Nanoprimer technology is designed to … [Read more…]

U.S.-U.A.E. Business Council Names Dr. Tomislav Mihaljevic, CEO and President of Cleveland Clinic, Co-Chairman of Board of Directors

WASHINGTON–(BUSINESS WIRE)–Today, the U.S.-U.A.E. Business Council named Dr. Tomislav Mihaljevic, Chief Executive Officer and President of Cleveland Clinic, as Co- Chairman of its Board of Directors. Dr. Mihaljevic joins H.E. Waleed al Mokarrab Al Muhairi, Deputy Group CEO of Mubadala Investment Company, who serves as Co-Chairman of the Council. In his current role as CEO … [Read more…]